Community Healthcare Trust Inc (CHCT)

Insider Trading Filed: 2026-05-08

Key Insights

Director Van Horn R. Lawrence acquired 6,222 shares of CHCT common stock on 05/07/2026 at $0 price, indicating a grant or award rather than an open market purchase, bringing total beneficial ownership to 94,724 shares.
The zero-dollar transaction price suggests this acquisition was compensation-related (likely restricted stock grant or equity incentive plan award) rather than a discretionary insider buy, which is less indicative of confidence in the stock's valuation.
As a Director holding over 94,000 shares post-transaction, Lawrence maintains meaningful skin in the game, though the nature of the acquisition (grant vs. purchase) provides limited insight into insider sentiment regarding future stock performance.

Insider Trading Filed: 2026-05-08

Key Insights

Director Alan Gardner acquired 6,222 shares of CHCT common stock on 05/07/2026 at $0 per share, indicating this was likely a stock grant, dividend reinvestment, or compensation-related transaction rather than open market purchase.
Following the transaction, Gardner's beneficial ownership increased to 96,860 shares held directly, suggesting a meaningful stake in the company and alignment with shareholder interests.
The transaction was filed by attorney-in-fact Nathanael P. Kibler on 05/08/2026, one day after the transaction date, which is compliant with SEC filing requirements.
This appears to be a routine director compensation or equity grant rather than a discretionary market purchase, limiting the signal value regarding insider confidence in the stock's valuation.

Insider Trading Filed: 2026-05-08

Key Insights

Director Robert Z. Hensley acquired 6,222 shares of CHCT common stock on 05/07/2026 at $0 price, indicating a stock grant or equity compensation rather than open market purchase.
Following this transaction, Hensley's direct beneficial ownership increased to 89,666 shares, demonstrating significant insider stake alignment with shareholder interests.
The filing shows insider equity compensation activity typical for board members, with no indication of concern-raising selling patterns or insider disposition.

Insider Trading Filed: 2026-05-08

Key Insights

Director Cathrine Cotman acquired 6,222 shares of CHCT common stock on 05/07/2026 at $0 price, indicating a grant or award rather than open market purchase, bringing total beneficial ownership to 43,857 shares.
The transaction was executed through an attorney-in-fact (Nathanael P. Kibler), suggesting this was part of a formal compensation or equity incentive plan rather than a discretionary insider trade.
No derivative securities activity is reported, indicating no options or warrants were exercised, which limits visibility into potential larger insider accumulation strategies.

Insider Trading Filed: 2026-05-08

Key Insights

Director Claire M. Gulmi acquired 6,222 shares of CHCT common stock on 05/07/2026 at $0 price, indicating a grant or equity compensation rather than open market purchase, with total beneficial ownership reaching 63,862 shares.
The transaction was executed at zero dollar consideration, suggesting this represents restricted stock awards, performance shares, or other equity incentive compensation typical for board members rather than voluntary insider buying.
The filing shows routine director compensation activity with no indication of material insider selling pressure, which is neutral to slightly positive from a governance perspective.

Current Report Filed: 2026-05-07

Key Insights

Strong shareholder participation with 88.27% of outstanding shares voting at the annual meeting indicates healthy investor engagement and confidence in the company's governance.
All six directors were elected with substantial support, with vote totals ranging from 21.05 to 21.60 million votes for, demonstrating solid board approval and no significant shareholder dissent.
Say-on-pay proposal received strong approval with 91.5% support (19.97M for vs 1.86M against), suggesting shareholders endorse the executive compensation structure and management performance.
BDO USA, P.C. was overwhelmingly ratified as independent auditor with 99.1% approval and zero broker non-votes, reflecting confidence in the audit function and financial reporting integrity.
Shareholders voted for annual frequency of compensation advisory votes (21.41M votes) over multi-year alternatives, indicating preference for ongoing governance oversight of executive pay.

Quarterly Report Filed: 2026-05-05

Key Insights

Community Healthcare Trust filed Q1 2026 10-Q on May 5, 2026, covering the period ending March 31, 2026, indicating active portfolio management with acquisitions during the quarter including a Pinellas Park, FL property.
The filing reflects a diversified real estate portfolio across multiple healthcare segments (medical office buildings, inpatient rehabilitation hospitals, behavioral facilities, surgical centers, and long-term acute care facilities) with geographic diversification across FL, TX, IL, OH, PA and other states.
The company maintains a credit facility structure with revolving credit and multiple term loans (A4, A5) under a third amended and restated credit agreement, suggesting active debt management and refinancing activity as of Q1 2026.

Current Report Filed: 2026-05-05

Key Insights

Community Healthcare Trust announced Q1 2026 earnings results on May 5, 2026, providing investors with updated financial performance and operational metrics for the first quarter ended March 31, 2026.
The company furnished supplemental information and an investor presentation alongside earnings, indicating active investor relations engagement and transparency in communicating quarterly performance.
The 8-K filing is routine earnings disclosure with no material agreements, leadership changes, or significant transactions reported, representing standard quarterly reporting by the healthcare REIT.

Annual Report Filed: 2026-02-17

Key Insights

Community Healthcare Trust Inc. (CHCT) operates in the healthcare real estate sector, leasing properties to medical providers across the United States.
The company's revenue and profitability have been relatively stable over the past 3 years, with consistent occupancy rates and tenant lease renewals.
However, CHCT faces industry-wide risks such as tenant concentration, geographic concentration, and potential changes in healthcare regulations that could impact its business model.

Current Report Filed: 2026-02-17

Key Insights

Community Healthcare Trust Inc (CHCT) reported earnings for the fourth quarter of 2025, which were in line with expectations. The company's revenue and occupancy rates remained stable compared to the previous quarter.
CHCT provided supplemental information and investor presentation materials on its website, indicating continued focus on transparency and communication with investors.
The company did not disclose any material changes in its portfolio, leadership, or strategic direction, suggesting a continuation of its existing business plan.

Insider Trading Filed: 2026-01-20

Key Insights

The CEO and President, David H. Dupuy, has received a significant amount of restricted stock as part of his 2026 compensation, indicating alignment with shareholder interests.
Dupuy acquired 29,941 shares of common stock at $16.70 per share, increasing his direct beneficial ownership to 534,245 shares.
The restricted stock award with a 5-year restriction period suggests long-term commitment and confidence in the company's future performance.

Insider Trading Filed: 2026-01-20

Key Insights

William G. Monroe IV, the Executive Vice President and CFO, has been awarded 29,605 shares of restricted stock as part of his 2026 compensation package. This indicates management's confidence in the company's future performance.
The restricted stock has an 8-year vesting period, which aligns the executive's interests with long-term shareholder value creation.
The purchase price of $16.70 per share is based on the average stock price in the 10 trading days preceding the transaction, suggesting the company's stock is trading at a fair value.

Insider Trading Filed: 2026-01-20

Key Insights

The reporting person, Leigh Ann Stach, who is the Executive Vice President and Chief Accounting Officer of Community Healthcare Trust Inc (CHCT), acquired 17,889 shares of the company's common stock as part of a compensation agreement to take 50% of her 2026 salary in restricted stock.
Stach also had 4,643 shares withheld for tax purposes, indicating she is still bullish on the company and retaining a significant portion of the awarded shares.
The acquisition price of $16.70 per share suggests the company's stock is considered undervalued by the reporting person, who is an insider and key executive.

Current Report Filed: 2026-01-09

Key Insights

Community Healthcare Trust Inc (CHCT) has approved and adopted the Second Amendment to its Fourth Amended and Restated Alignment of Interest Program, reserving an additional 500,000 restricted shares for issuance to employees, officers, and directors in lieu of cash compensation.
This move aligns the interests of the company's leadership with shareholders by incentivizing them through equity-based compensation.
The additional share reserve suggests the company is focused on retaining and incentivizing its key talent, which could be positive for long-term growth and shareholder value.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information